China Shesays Medical Cosmetology Inc (CSAY) financial statements (2022 and earlier)
Company profile
| Business Address |
NEW NO. 83, XINNAN ROAD, WUHOU DISTRICT SICHUAN PROVINCE, 610041 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| SIC | 8062 - General Medical and Surgical Hospitals (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 12/31/2012 | |||
|---|---|---|---|
| ASSETS | |||
| Current Assets | |||
| Cash, cash equivalents, and short-term investments | 840 | ||
| Cash and cash equivalents | 840 | ||
| Receivables | 1,011 | ||
| Inventory, net of allowances, customer advances and progress billings | 646 | ||
| Inventory | 646 | ||
| Prepaid expense | 166 | ||
| Advances on inventory purchases | 205 | ||
| Deposits current assets | 206 | ||
| Deferred tax assets | 480 | ||
| Other undisclosed current assets | 878 | ||
| Total current assets: | 4,431 | ||
| Noncurrent Assets | |||
| Property, plant and equipment | 9,130 | ||
| Other undisclosed noncurrent assets | 480 | ||
| Total noncurrent assets: | 9,610 | ||
| TOTAL ASSETS: | 14,041 | ||
| LIABILITIES AND EQUITY | |||
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities, including: | 3,940 | ||
| Accounts payable | 819 | ||
| Accrued liabilities | 830 | ||
| Taxes payable | 11 | ||
| Accounts payable and other accrued liabilities | 3,940 | ||
| Other undisclosed accounts payable and accrued liabilities | (1,661) | ||
| Debt | 3,804 | ||
| Deferred revenue and credits | 143 | ||
| Other liabilities | 1,415 | ||
| Other undisclosed current liabilities | 1,349 | ||
| Total current liabilities: | 10,651 | ||
| Noncurrent Liabilities | |||
| Other undisclosed noncurrent liabilities | 144 | ||
| Total noncurrent liabilities: | 144 | ||
| Total liabilities: | 10,796 | ||
| Stockholders' equity | |||
| Stockholders' equity attributable to parent, including: | 3,389 | ||
| Common stock | 19 | ||
| Additional paid in capital | 2,174 | ||
| Accumulated other comprehensive income | 301 | ||
| Retained earnings | 752 | ||
| Other undisclosed stockholders' equity attributable to parent | 144 | ||
| Stockholders' equity attributable to noncontrolling interest | 144 | ||
| Other undisclosed stockholders' equity | (288) | ||
| Total stockholders' equity: | 3,245 | ||
| TOTAL LIABILITIES AND EQUITY: | 14,041 | ||
Income statement (P&L) ($ in thousands)
| 12/31/2012 | ||
|---|---|---|
| Revenues | 22,049 | |
| Cost of revenue | (7,945) | |
| Cost of goods and services sold | (2,727) | |
| Gross profit: | 14,104 | |
| Operating expenses | (13,138) | |
| Operating income: | 966 | |
| Nonoperating expense | (436) | |
| Other nonoperating expense | (71) | |
| Interest and debt expense | (390) | |
| Other undisclosed income from continuing operations before equity method investments, income taxes | 390 | |
| Income from continuing operations before income taxes: | 530 | |
| Income tax expense | (291) | |
| Net income: | 239 | |
| Net loss attributable to noncontrolling interest | (17) | |
| Net income available to common stockholders, diluted: | 223 | |
Comprehensive Income ($ in thousands)
| 12/31/2012 | ||
|---|---|---|
| Net income: | 239 | |
| Comprehensive income: | 239 | |
| Comprehensive income, net of tax, attributable to noncontrolling interest | 17 | |
| Other undisclosed comprehensive income, net of tax, attributable to parent | 4 | |
| Comprehensive income, net of tax, attributable to parent: | 260 | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.